AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $16.52M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| SVY | Thursdays Gossan - New Thick Intercept in SMD016 | PRICE SENSITIVE | 20/04/18 | |
| SVY | Valuation and Listing Rule 7.1A.4(b) and 3.10.5A Information | 13/04/18 | ||
| SVY | Appendix 3B | 13/04/18 | ||
| SVY | New 124m Intercept of Porphyry M Veins | PRICE SENSITIVE | 10/04/18 | |
| SVY | Results of Meeting | 05/04/18 | ||
| SVY | Half Yearly Report and Accounts | 13/03/18 | ||
| SVY | Intercept of Bendigo-like Source Rocks at Toora West | PRICE SENSITIVE | 13/03/18 | |
| SVY | Notice of General Meeting/Proxy Form | 06/03/18 | ||
| SVY | Thursdays Gossan - New 80m Intercept of Porphyry M Veins | PRICE SENSITIVE | 16/02/18 | |
| SVY Thursdays Gossan - New Thick Intercept in SMD016 | |||
| 20/04/18 | PRICE SENSITIVE | ||
| SVY Valuation and Listing Rule 7.1A.4(b) and 3.10.5A Information | |||
| 13/04/18 | |||
| SVY Appendix 3B | |||
| 13/04/18 | |||
| SVY New 124m Intercept of Porphyry M Veins | |||
| 10/04/18 | PRICE SENSITIVE | ||
| SVY Results of Meeting | |||
| 05/04/18 | |||
| SVY Half Yearly Report and Accounts | |||
| 13/03/18 | |||
| SVY Intercept of Bendigo-like Source Rocks at Toora West | |||
| 13/03/18 | PRICE SENSITIVE | ||
| SVY Notice of General Meeting/Proxy Form | |||
| 06/03/18 | |||
| SVY Thursdays Gossan - New 80m Intercept of Porphyry M Veins | |||
| 16/02/18 | PRICE SENSITIVE | ||
